Endometrial intraepithelial neoplasia [EIN]
ICD-10 N85.02 is a billable code used to indicate a diagnosis of endometrial intraepithelial neoplasia [ein].
Endometrial intraepithelial neoplasia (EIN) is a precancerous condition characterized by abnormal growth of cells in the lining of the uterus (endometrium). It is considered a precursor to endometrial carcinoma and is often identified through endometrial biopsy. EIN is typically diagnosed in women of reproductive age to postmenopausal women, often presenting with abnormal uterine bleeding or other menstrual irregularities. The condition is associated with various risk factors, including obesity, diabetes, and hormonal imbalances, particularly excess estrogen without adequate progesterone. The diagnosis of EIN is confirmed histologically, showing atypical glandular cells within the endometrial epithelium. Management may involve close monitoring, hormonal therapy, or surgical intervention, depending on the severity of the atypia and the patient's overall health and reproductive plans. Accurate coding of EIN is crucial for appropriate treatment planning and monitoring, as well as for research and epidemiological studies.
Detailed pathology reports, patient history, and treatment plans.
Patients presenting with abnormal uterine bleeding, abnormal Pap smears, or findings on imaging studies.
Ensure accurate documentation of histological findings and any treatments provided.
Comprehensive cancer staging and treatment documentation.
Patients undergoing evaluation for potential endometrial cancer following an EIN diagnosis.
Document any multidisciplinary team discussions regarding treatment options.
Used to confirm diagnosis of EIN.
Pathology report confirming EIN diagnosis.
Gynecologists should ensure thorough documentation of indications for biopsy.
Accurate coding of EIN is crucial for appropriate treatment planning, monitoring of precancerous conditions, and ensuring proper reimbursement for services rendered.
